跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
SINGULAIR montelukast 4 mg (as sodium) tablet blister pack
Approved
STANDARD
SINGULAIR montelukast 4 mg (as sodium) tablet blister pack
ORGANON PHARMA PTY LTD
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
5c305b7a3e814e65
Company
ORGANON PHARMA PTY LTD
Type
Standard
Approval Details
Approval Id
5c305b7a3e814e65
Product Name
SINGULAIR montelukast 4 mg (as sodium) tablet blister pack
Artg Id
74890
Artg Name
SINGULAIR montelukast 4 mg (as sodium) tablet blister pack
Sponsor
ORGANON PHARMA PTY LTD
Company Detail Path
/organization/organon-pharma-pty-ltd
Artg Date
2001-05-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-04106-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
5c305b7a3e814e65
Type
Standard
Back to TGA Approvals
SINGULAIR montelukast 4 mg (as sodium) tablet blister pack - TGA Drug Approval Details